Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 7.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,346,111 shares of the real estate investment trust’s stock after buying an additional 92,236 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Ventas were worth $104,095,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BI Asset Management Fondsmaeglerselskab A S increased its stake in Ventas by 97.7% during the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after buying an additional 18,146 shares during the period. Schroder Investment Management Group increased its stake in Ventas by 3.6% during the 3rd quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock worth $170,946,000 after buying an additional 85,340 shares during the period. Vanguard Group Inc. increased its stake in Ventas by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after buying an additional 1,802,515 shares during the period. Aberdeen Group plc increased its stake in Ventas by 8.3% during the 3rd quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock worth $109,985,000 after buying an additional 120,825 shares during the period. Finally, Krilogy Financial LLC purchased a new stake in Ventas during the 3rd quarter worth $919,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Price Performance
Shares of NYSE:VTR opened at $86.51 on Friday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $88.50. The firm has a 50-day simple moving average of $84.81 and a 200 day simple moving average of $80.56. The company has a market cap of $42.06 billion, a PE ratio of 157.28, a P/E/G ratio of 2.13 and a beta of 0.74.
Wall Street Analysts Forecast Growth
VTR has been the topic of several analyst reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a research note on Friday, March 27th. Morgan Stanley set a $90.00 target price on shares of Ventas in a research report on Friday, February 13th. Mizuho boosted their target price on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 4th. Citigroup boosted their target price on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Finally, KeyCorp boosted their target price on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas has a consensus rating of “Moderate Buy” and an average target price of $93.50.
View Our Latest Stock Report on VTR
Insider Buying and Selling at Ventas
In related news, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. This represents a 32.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.53% of the stock is currently owned by corporate insiders.
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Recommended Stories
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
